Unknown

Dataset Information

0

Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation.

ABSTRACT:

SUBMITTER: Leisman DE 

PROVIDER: S-EPMC7186535 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation.

Leisman Daniel E DE   Deutschman Clifford S CS   Legrand Matthieu M  

Intensive care medicine 20200428 6

Similar Datasets

Unknown Pulmonary Vascular Thrombosis in COVID-19 Pneumonia.
| S-EPMC7836419 | biostudies-literature
Unknown Inflammation and vascular dysfunction: The negative synergistic combination of diabetes and COVID-19.
| S-EPMC9349661 | biostudies-literature
Unknown Dysregulated Neutrophil Phenotype and Function in Hospitalised Non-ICU COVID-19 Pneumonia.
| S-EPMC9496854 | biostudies-literature
Unknown Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
| S-EPMC7412750 | biostudies-literature
Unknown SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.
| S-EPMC7525265 | biostudies-literature
Unknown Erythrocytes Induce Vascular Dysfunction in COVID-19.
| S-EPMC8849181 | biostudies-literature
Unknown Lipoprotein(a) during COVID-19 hospitalization: Thrombosis, inflammation, and mortality.
| S-EPMC9343714 | biostudies-literature
Unknown Acute COVID-19 induced fulminant systemic vascular thrombosis: A novel entity.
| S-EPMC7427520 | biostudies-literature
Unknown Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19.
| S-EPMC8648369 | biostudies-literature
Unknown Vascular Complications of Long COVID-From Endothelial Dysfunction to Systemic Thrombosis: A Systematic Review.
| S-EPMC12786942 | biostudies-literature